Iceland· IS-EU/1/25/2014/001
MyQorzo
A aficamten product containing aficamten, registered in Iceland by Cytokinetics (Ireland) Limited. The same ATC class is registered in 3 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Aficamten is registered in 3 of 19 countries.
Countries holding a registration under ATC Aficamten (aficamten), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 3 of them publish a price we can compare per daily dose
Aficamten · ATC Aficamten
3 / 19 countries
- Icelandprice
- Spainprice
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Aficamten
- Manufacturer
- Cytokinetics (Ireland) Limited
- Country
- Iceland (IS)
- ATC code
- Aficamten
- ATC class
- Aficamten
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aficamten in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumMyqorzo 5 mgCytokinetics (Ireland) Limited
- CzechiaMYQORZOCytokinetics (Ireland) Limited, Dublin
- SpainMYQORZO 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULACytokinetics (Ireland) Limited
- FinlandMYQORZOCytokinetics (Ireland) Limited
- IrelandMYQORZO 5 mg film-coated tabletsCytokinetics (Ireland) Limited
- NetherlandsMYQORZO 5 mg filmomhulde tablettenCytokinetics (Ireland) Limited
- PolandMyqorzoCytokinetics (Ireland) Limited
- SwedenMYQORZO 5 mg Filmdragerad tablettCytokinetics (Ireland) Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f307ad72-7d48-4ca7-b83a-e0ee7c2bec3f GET /v1/drugs/f307ad72-7d48-4ca7-b83a-e0ee7c2bec3f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": ".",
"marketed": false,
"strength": "5 mg",
"ma_number": "EU/1/25/2014/001",
"substance": "Aficamten",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í hjartasjúkdómum.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "46065"
}See everything about aficamten.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.